Skip to Content

Guardant Health Inc

GH: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$24.00GqcpVdcfcvpd

Research & Development Is Driving Medical Breakthroughs and Exponential Growth Opportunities

Healthcare innovation represents a key area of exponential growth, and we think the scientific community’s understanding of medical interventions has increased significantly over time and will likely continue to grow in a non-linear upward trajectory during the decades ahead. Within healthcare innovation, we view two key areas of explosive growth potential: 1) innovative therapies and 2) innovative devices and diagnostics. High spending on research and development, massive growth in scientific advancements (and medical articles), steep increases in clinical studies, and major growth in medical patents all support exponential growth opportunities in key healthcare areas. This innovation not only supports strong growth potential but also the intangible assets that are the basis of many economic moats and leadership positions in healthcare.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of GH so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center